Drug recall · October 15, 2014
Truvada recall
Why: Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1
- Lots / codes
TRUVADA (NDA 21-752; NDC 61958-0701-1) Lot# 002808, Expiration Date: 31 December 2017
- Quantity
- 10,317 bottles
- Company
- Gilead Sciences, Inc., Foster City, CA
- Distribution
- Nationwide
- Initiated
- September 30, 2014 · Voluntary: Firm initiated
- Classified
- October 9, 2014
- Reported
- October 15, 2014
- Ended
- May 11, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Truvada
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.